Genmab A/S (GMAB)
25.14
-0.44
(-1.72%)
USD |
NASDAQ |
Jun 28, 16:00
25.12
-0.02
(-0.08%)
After-Hours: 20:00
Genmab Enterprise Value: 11.72B for June 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 28, 2024 | 11.72B |
June 27, 2024 | 12.00B |
June 26, 2024 | 12.05B |
June 25, 2024 | 12.12B |
June 24, 2024 | 12.15B |
June 21, 2024 | 12.28B |
June 20, 2024 | 12.27B |
June 18, 2024 | 12.22B |
June 17, 2024 | 12.21B |
June 14, 2024 | 12.47B |
June 13, 2024 | 12.68B |
June 12, 2024 | 12.91B |
June 11, 2024 | 13.27B |
June 10, 2024 | 13.65B |
June 07, 2024 | 13.56B |
June 06, 2024 | 14.06B |
June 05, 2024 | 14.19B |
June 04, 2024 | 14.03B |
June 03, 2024 | 14.24B |
May 31, 2024 | 13.84B |
May 30, 2024 | 13.77B |
May 29, 2024 | 13.77B |
May 28, 2024 | 13.78B |
May 24, 2024 | 13.78B |
May 23, 2024 | 14.66B |
Date | Value |
---|---|
May 22, 2024 | 14.96B |
May 21, 2024 | 14.54B |
May 20, 2024 | 14.89B |
May 17, 2024 | 15.07B |
May 16, 2024 | 14.86B |
May 15, 2024 | 15.23B |
May 14, 2024 | 14.78B |
May 13, 2024 | 14.56B |
May 10, 2024 | 14.35B |
May 09, 2024 | 14.33B |
May 08, 2024 | 14.32B |
May 07, 2024 | 14.64B |
May 06, 2024 | 14.47B |
May 03, 2024 | 14.91B |
May 02, 2024 | 13.64B |
May 01, 2024 | 14.31B |
April 30, 2024 | 13.62B |
April 29, 2024 | 14.19B |
April 26, 2024 | 13.92B |
April 25, 2024 | 13.53B |
April 24, 2024 | 14.18B |
April 23, 2024 | 14.24B |
April 22, 2024 | 14.51B |
April 19, 2024 | 14.33B |
April 18, 2024 | 14.13B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.501B
Minimum
Mar 16 2020
28.99B
Maximum
Sep 03 2021
19.21B
Average
20.19B
Median
Enterprise Value Benchmarks
Novo Nordisk A/S | 638.28B |
Ascendis Pharma A/S | 8.166B |
Galecto Inc | -13.72M |
Evaxion Biotech AS | 3.958M |
IO Biotech Inc | -40.90M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 193.00M |
Revenue (Quarterly) | 603.46M |
Total Expenses (Quarterly) | 486.79M |
EPS Diluted (Quarterly) | 0.2939 |
Gross Profit Margin (Quarterly) | 95.53% |
Profit Margin (Quarterly) | 31.98% |
Earnings Yield | 4.80% |
Operating Earnings Yield | 5.00% |
Normalized Earnings Yield | 4.456 |